Charles River Laboratories International, Inc. (CRL) reported Wednesday that its fourth-quarter profit and revenues climbed from last year, above market estimates. Looking ahead for fiscal 2023, the company issued weak earnings outlook, below market, despite higher revenue view.
from RTT - Before the Bell https://ift.tt/5KtSZNm
via IFTTT
No comments:
Post a Comment